Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alx Oncology Holdings Inc (NQ: ALXO )

8.050 +0.110 (+1.39%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 418,625
Open 7.920
Bid (Size) 7.990 (12)
Ask (Size) 35.00 (1)
Prev. Close 7.940
Today's Range 7.600 - 8.180
52wk Range 7.590 - 81.19
Shares Outstanding 40,680,947
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
ALX Oncology Holdings: Q4 Earnings Insights
ALX Oncology Holdings (NASDAQ:ALXO) reported its Q4 earnings results on Monday, February 28, 2022 at 07:00 AM. Here's what investors need to know about the announcement... 
Via Benzinga
The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga

Performance

YTD
-63.51%
-63.51%
1 Month
-41.07%
-41.07%
3 Month
-52.23%
-52.23%
6 Month
-76.03%
-76.03%
1 Year
-85.74%
-85.74%

More News

Read More
ALX Oncology's Evorpacept Gets Orphan Drug Tag For Gastric Cancer
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Gastrointestinal Cancer Treatment Trials Driven by Rising Incidences of Colorectal Cancer
Via FinancialNewsMedia
Topics Death
Exposures Death
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2021
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Via Benzinga
ALX Oncology's Evorpacept Data Fails To Impress At ASH Presentation
Via Benzinga
58 Biggest Movers From Yesterday
Via Benzinga
40 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
75 Biggest Movers From Yesterday
Via Benzinga
ALX Oncology Falls After Updated Data For Solid Tumors Candidate
Via Benzinga
Zymeworks and ALX Oncology Announce First Patient Dosed in Phase 1b/2 Clinical Trial of Zanidatamab and Evorpacept (ALX148) in Patients with Advanced HER2-Expressing Breast Cancer and Other Solid Tumors
From Zymeworks Inc.
Via Business Wire
58 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
A Peek Into The Markets: US Stock Futures Climb Ahead Of GDP, Jobless Claims Data
Via Benzinga
Topics Stocks
Exposures US Equities
81 Biggest Movers From Yesterday
Via Benzinga
55 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
The 3 Best Biotech Stocks to Buy Right Now
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2021
Via Benzinga
Jon Najarian Sees Unusual Options Activity In Lucid Motors, Kura Oncology And More
Via Benzinga
So What's Going On With ALX Oncology's Stock?
Via Benzinga
60 Biggest Movers From Yesterday
Via Benzinga
35 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Odonate Therapeutics, Opthea, ALX Oncology, Advaxis and Provention Bio Are Moving Today
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.